stockrowKrystal Biotech, Inc. (KRYS) vs Vaxcyte, Inc. (PCVX)
- Krystal Biotech, Inc. KRYS 300.31 +0.02%
- Vaxcyte, Inc. PCVX 63.82 +3.07%
Krystal Biotech, Inc. and Vaxcyte, Inc. are both Biotechnology companies. Krystal Biotech, Inc. and Vaxcyte, Inc. are of similar size ($9.8B and $8.9B). Vaxcyte, Inc. has negative trailing earnings, so its P/E is not meaningful; Krystal Biotech, Inc. trades at 39.2×. Krystal Biotech, Inc. has the higher net margin (47.9% vs 0.00%) and the higher return on invested capital (27.2% vs −59.5%). Across the 14 metrics below, Krystal Biotech, Inc. leads on 13 and Vaxcyte, Inc. on 1.
Valuation
Profitability
| Metric | KRYS | PCVX | Biotechnology median |
|---|---|---|---|
| Gross margin | 94.27% | 0.00% | 68.51% |
| Operating margin | 48.41% | 0.00% | 0.00% |
| Net margin | 47.91% | 0.00% | 0.00% |
| Free cash flow margin | 65.97% | 0.00% | 0.00% |
| Return on equity | 17.50% | (42.68%) | (51.96%) |
| Return on assets | 15.93% | (37.28%) | (46.06%) |
| Return on invested capital | 27.15% | (59.47%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack